Effects of cataractogenesis on the CDP-choline pathway: changes in ATP concentration and phosphocholine synthesis during and after exposure of rat lenses to sugars in vitro and in vivo.
We measured choline influx and phosphorylation, ATP concentration ([ATP]), choline kinase activity and lens swelling during formation and partial reversal of sugar cataracts in rat lenses incubated with xylose or galactose and in lenses of galactosemic rats. [ATP] and phosphocholine (P-Cho) synthesis decreased about 60 and 40% after 4 h in normal rat lenses incubated up to 24 h in medium containing 30 mM xylose and partially recovered when the lenses were then removed from the xylose. Incubation with the somewhat less cataractogenic sugar galactose decreased P-Cho synthesis but had little effect on [ATP]. P-Cho synthesis decreased rapidly in the lenses of rats fed a 50% galactose diet, but began recovery by the third day on this diet. [ATP] decreased for at least 10 days during the galactose diet and did not recover, even with resumption of the control diet (50% starch) after 4 or 7 days. The results of in vitro and in vivo sugar cataractogenesis differed from each other in several respects, including effects on choline influx and the degree to which the changes were reversible. The in vitro and in vivo sugar cataracts, however, could both produce swelling and opacification of the lens and decreased P-Cho synthesis and [ATP]. Neither model caused a substantial change in the choline kinase activity (as measured in cell-free assays). The data did not generally support the hypothesis that decreased [ATP] causes decreased P-Cho synthesis.
Liu
Ying
Y
Department of Molecular Sciences, University of Tennessee Health Science Center, Memphis, Tenn., USA.
Blum
Penny S
PS
Pabst
Diana M
DM
Chakrabarti
Ipsit
I
Jernigan
Howard M
HM
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport; D002386:Cataract / Q000378:metabolism*; D002794:Choline / Q000378:metabolism; D002797:Choline Kinase / Q000378:metabolism; D003566:Cytidine Diphosphate Choline / Q000378:metabolism; D005690:Galactose / Q000494:pharmacology*; D005693:Galactosemias / Q000378:metabolism*; D007908:Lens, Crystalline / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D009924:Organ Culture Techniques; D010766:Phosphorylation; D010767:Phosphorylcholine / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction; D014994:Xylose / Q000494:pharmacology*
D010767:Phosphorylcholine; D003566:Cytidine Diphosphate Choline; D000255:Adenosine Triphosphate; D014994:Xylose; D002797:Choline Kinase; D002794:Choline; D005690:Galactose